
Health and Human Services Secretary Kathleen Sebelius toured the plant, whose cell-based technology is designed to be cleaner, quicker and more predictable than the current way most influenza vaccines are made using eggs and will help alleviate the U.S. dependence on imported vaccines.
The bioreactors used to incubate the cells with the virus should also be able to scale up more quickly to make larger quantities of vaccine when needed -- such as during pandemics.'
Read more...Related Post:
new flu vaccine lab
business booming for novartis
Novartis new lav
Widget by [ Iptek-4u ]